145 related articles for article (PubMed ID: 4206390)
1. The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
Roberts NB; Taylor WH
Clin Sci Mol Med; 1973 Aug; 45(2):213-24. PubMed ID: 4206390
[No Abstract] [Full Text] [Related]
2. Effect of triterpenoids related to carbenoxolone upon human pepsins and pepsinogens and upon bovine trypsin and chymotrypsin.
Waft LA; Roberts NB; Taylor WH
Clin Sci Mol Med; 1974 Apr; 46(4):519-26. PubMed ID: 4597977
[No Abstract] [Full Text] [Related]
3. The inhibition by carbenoxolone sodium of individual human pepsinogens and pepsins.
Roberts NB; Taylor WH
Clin Sci; 1973 Feb; 44(2):6P-7P passim. PubMed ID: 4579239
[No Abstract] [Full Text] [Related]
4. Effect of carbenoxolone on ionic fluxes across normal gastric mucosa and that associated with gastric ulcer.
Ivey KJ; Gray C
Aust N Z J Med; 1973 Oct; 3(5):451-6. PubMed ID: 4591118
[No Abstract] [Full Text] [Related]
5. The actions of carbenoxolone on enzymes and their relation to its therapeutic effect.
Roberts NB; Taylor WH
Scand J Gastroenterol Suppl; 1980; 65():11-7. PubMed ID: 6782651
[TBL] [Abstract][Full Text] [Related]
6. Pepsins, peptic activity, and peptic inhibitors.
Samloff IM
J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclo-alkyl lactamimides upon human pepsins and pepsinogens.
Roberts NB; Taylor WH
Clin Sci Mol Med; 1978 Feb; 54(2):181-5. PubMed ID: 340116
[TBL] [Abstract][Full Text] [Related]
8. The pepsins from human gastric mucosal extracts.
Etherington DJ; Taylor WH
Biochem J; 1970 Jul; 118(4):587-94. PubMed ID: 4921276
[TBL] [Abstract][Full Text] [Related]
9. [Antacids and antipeptic agents].
Belousov AS; Mamedova LD; Zel'din VE; Rakitskaia LG; Loranskaia ID
Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
[No Abstract] [Full Text] [Related]
10. Carbenoxolone sodium in the treatment of peptic ulcer. A review.
Lewis JR
JAMA; 1974 Jul; 229(4):460-2. PubMed ID: 4600402
[No Abstract] [Full Text] [Related]
11. [Enzyme-forming function of the stomach in patients with peptic ulcer and its dynamics in the process of therapy].
Dzharimov AIa
Ter Arkh; 1974; 46(4):118-20. PubMed ID: 4610865
[No Abstract] [Full Text] [Related]
12. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
Henman FD
Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
[TBL] [Abstract][Full Text] [Related]
13. Reversible inactivation of the potential pepsin activity of pepsinogen by alcohols.
Neumann H; Shinitzky M
Biochemistry; 1971 Nov; 10(23):4335-42. PubMed ID: 5001736
[No Abstract] [Full Text] [Related]
14. Pepsinogens, pepsins, and peptic ulcer.
Samloff IM; Taggart RT
Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
[TBL] [Abstract][Full Text] [Related]
15. Letter: Carbenoxolone and gastric secretion.
Walker V; Taylor WH
Lancet; 1975 Jun; 1(7920):1335. PubMed ID: 49532
[No Abstract] [Full Text] [Related]
16. Relationship between site of peptic ulceration and gastric acid-peptic activity: new evaluation of gastric analysis in patients with acute gastric bleeding and chronic peptic ulcer.
Nagamachi Y; Nakamura T
Gastroenterol Jpn; 1978; 13(2):77-84. PubMed ID: 27412
[TBL] [Abstract][Full Text] [Related]
17. Proceedings: The effects of aspirin, carbenoxolone, and gefarnate on the gastric mucosal potential difference in man.
Hossenbocus A; Colin-Jones DG
Gut; 1974 Apr; 15(4):335-6. PubMed ID: 4834559
[No Abstract] [Full Text] [Related]
18. Pepsinogens and pepsins.
Turner MD
Gut; 1968 Apr; 9(2):134-8. PubMed ID: 4871722
[No Abstract] [Full Text] [Related]
19. Carbenoxolone sodium.
Sircus W
Gut; 1972 Oct; 13(10):816-24. PubMed ID: 4564085
[No Abstract] [Full Text] [Related]
20. Effect of glycyrrhetinic acid on the cyclic nucleotide system of the rat stomach.
Amer MS; McKinney GR; Akcasu A
Biochem Pharmacol; 1974 Nov; 23(22):3085-92. PubMed ID: 4155299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
